Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment
Year: 2014
Type: article
Source: MedChemComm
DOI: 10.1039/c4md00350k
Authors: De-Si Pan, Qian-Jiao Yang, Xin Fu, Song Shan, Jing-Zhong Zhu, Kun Zhang, Zhi-Bin Li, Zhi-Qiang Ning, Xian-Ping Lu
Institution: Shenzhen Chipscreen Biosciences Co.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2090033540